Expectorant Guaifenesin Extended-release Tablet
NDC Package 81179-007-04
Package Information
Expectorant Guaifenesin Extended-release (guaifenesin) tablets is do not crush, chew, or break tablettake with a full glass of waterthis product can be administered without regard for timing of mealsadults and children 12 years of age and over: 1 tablet every 12 hours. This formulation utilizes a tablet delivery system. Marketed by Yet Health Group Llc, this product is identified by NDC 81179-007 and is authorized under FDA application ANDA213420.
Identification & Billing
- RxCUI: 310621 - guaiFENesin 1200 MG 12HR Extended Release Oral Tablet
- RxCUI: 310621 - 12 HR guaifenesin 1200 MG Extended Release Oral Tablet
- RxCUI: 310621 - guaifenesin 1200 MG 12 HR Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 81179 - Yet Health Group Llc
- 81179-007 - Expectorant Guaifenesin Extended-release
- 81179-007-04 - 5 BLISTER PACK in 1 PACKAGE / 14 TABLET in 1 BLISTER PACK
- 81179-007 - Expectorant Guaifenesin Extended-release
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 81179-007-04 identifies a specific commercial package of 5 blister pack in 1 package / 14 tablet in 1 blister pack of Expectorant Guaifenesin Extended-release, a human over the counter drug labeled by Yet Health Group Llc. This tablet is formulated for oral use and contains guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Yet Health Group Llc on April 05, 2021. The current certification is valid through December 31, 2026.
How is this Yet Health Group Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 81179000704. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.